USP53 and colorectal cancer: Through bioinformatics analysis, Real-Time PCR, and immunohistochemistry, Shen found that USP53 was significantly down-regulated in colorectal cancer tissues, and its expression was negatively correlated with tumor size while positively correlated with chemotherapy response and prognosis of patients [97].